The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.
I agree the continental deal is great lets hope the figure are great too. by the time this starts the Maxwell saga should be over and we should be in profit by then so by the time this comes to fruition in 2024 for a 6 year deal we'll be flying.
If we post profit in feb this will rise quite quickly, if we then post profit at year end we’ll easily be hitting 14p at least. If we then win Maxwell (Tesla) case who knows where we’ll be. Tesla or Maxwell may just buy us out, but this could happen any time. Our lawyers are pretty confident of a win and they’ve successfully protected our IP twice before. We got accepted for litigation funding but this wasn’t put in place because we don’t need it right now and hopefully never will. There is a lot of ifs there but it all looks like everything is HR heading in the right direction. If Tesla try to take over this could be 24p tomorrow! highly unlikely but it could happen.
Anyway we’re on the right track now. Owning a business myself I know things don’t always go according to plan. Sometimes things go in the wrong direction and sometimes things go in an unexpected right direction. Like the Ioxus products and marine edge.
I'm hoping to be pleasantly surprised by the figures in feb. Less spending on Legal fees increased product line. Increased sales pipeline from 50-60million and although this is not sales it shows more companies are coming to us for developing projects, interest in our products is growing fast we're being recognised. IMO things will only go from strength to strength and once we post a profit this will fly. A positive outcome with Maxwell and who knows where the SP will end up.
Agree Vanilla my concern last year was the fact that the order book was depleted after being full for ages and the major sales would be toward the end of the financial year. Giving warning that the February results may not show profit or be as good as would expect. I suspected this might have been for a number of reasons. The production lines are more productive. They received more orders before they increased the price and shipped these efficiently. This in turn meant customers had more supply so held of reordering at the usual time meaning the order book dropped off. This rang kind of true when a couple of months later the order books had bounced back as customers had started ordering once again at a higher price. we also them have the added products that we have developed and launched and the whole range of products we got from the settlement deal we are now selling to Marine Edge. I think with the order books back up, the extra revenue from new products and the reduction in legal costs as we're now just waiting for the court date we may well see very good results in February. I'm more optimistic of this now than I was last year.
The estimated sales revenue for the year is set to be 8.3million up from 5.6 in 2022. Given that this year we won’t spend as much on legal fees (last year 2.4 million) . We can then add the new product launches and the deal with marine edge which the board expect to contribute a significant Im Mount to revenue this year and next. The coin cells launched in December are entering a market worth 4.2billion, if we can take 0.1% of that market on top of what we already have.
Like I’ve stated before the market control the SP not CPX. The market being us. if the majority of the market look at the SP and think that’s low I’m not investing then that’s upto the them or if the majority of the market dismiss the progress made in the last 2-3 years and only look at the disappointment before that then that’s upto them to the share price will remain low until CPX prove all these people wrong by posting profit. When that happens for many it will be too late.
I’m confident in CPX. they’ve delivered everything they said they would in the last 2-3 years and more. I’m confident they’ll continue to do this and this year CPX will make a profit. With profit one would assume the naysayers will be proved wrong and the share price will increase and I’ll make a handsome profit.
If talking about the companies good points and progress is ramping then I’m a ramper but the only bad point I see at the moment is the case with Maxwell but I’m not to fussed about that as the company or I can’t control the outcome. The laws here can and they’ve been successful twice so they seem to know wheat they’re doing. I’m aware that before I invested there was lots of false promises but it’s my understanding they were operating a licensing model which didn’t go well as the outcome of such deals is left in the hands of other companies. We now have changed that business model to become a manufacturer and distributor which as the figures I posted below seem to be going very well. I can’t think of any false promise they’ve made while I’ve been invested. As far as I can see everything is online with there expectations.
August 2020 was the last time we crossed the 200 WMA we then went from 2.95p to 13.75p in about 4 month. this was around the time we just finished installing the production line so we could reduce costs and make more profit from each item sold. Since then, we've retained 75% value of the mural customers we bought the line from. we've gained many other customers over the last 2year. We’ve successfully defended the our IP against infringement, we’ve successfully defended our IP through non-payment of royalties and we’re in the process of defending our IP from infringement with Maxwell (tesla).
Product sales revenue in 2020 up 27% on 2019
Product sales revenue in 2021 up 30% on 2020
Product sales revenue in 2022 up 44% on 2021
We’ve grown year on year and have lots more in the pipeline. We are also on the verge of crossing the 200 WMA again. Who know where this will go.
Oh I missed the continental deal out.
CAP-XX DMT220 prismatic supercaps for one of Continental's key automotive programs. The Sourcing Agreement for this design win covers the expected volumes for the model years 2024 through 2030.